Alpesh Amin
Hospitalist · Orange, CANPI 1457394801
Payments from drug & device makers
Across 453 payments — averaging $2049.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$134K
- Rigel Pharmaceuticals, Inc.$120K
- Pfizer$113K
- PTC Therapeutics, Inc.$100K
- Gilead$98K
- Octapharma USA, Inc.$73K
- plus $291K from 30 others
Across 2 payments — averaging $416.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$833
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 134 | $134,351 |
| Rigel Pharmaceuticals, Inc. | 5 | $119,727 |
| Pfizer(2 entities) | 47 | $112,579 |
| PTC Therapeutics, Inc. | 13 | $99,857 |
| Gilead | 115 | $98,328 |
| Octapharma USA, Inc. | 6 | $73,127 |
| Diasorin Molecular LLC | 1 | $42,250 |
| Amgen | 7 | $39,238 |
| Heron Therapeutics, Inc. | 7 | $38,254 |
| Sanofi US Services Inc. | 1 | $28,748 |
| Bayer | 35 | $28,294 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $15,939 |
| Novo Nordisk | 11 | $15,849 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $13,863 |
| Novartis | 11 | $13,772 |
| Mylan Specialty L.p. | 14 | $11,550 |
| Ferring Pharmaceuticals Inc. | 9 | $8,965 |
| Boehringer Ingelheim | 1 | $7,968 |
| Paratek Pharmaceuticals, Inc. | 5 | $6,409 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,800 |
| Lilly USA, LLC | 1 | $3,600 |
| Sanofi | 1 | $2,625 |
| Shionogi Inc | 1 | $2,080 |
| Invivyd Inc | 3 | $1,832 |
| Astrazeneca UK Limited | 1 | $1,800 |
| Dexcom, Inc. | 1 | $975 |
| AbbVie | 1 | $825 |
| Mylan Inc. | 2 | $824 |
| Novo Nordisk AS | 1 | $563 |
| Baxter Healthcare | 1 | $285 |
| Fisher & Paykel Healthcare Inc | 1 | $63 |
| Aimmune Therapeutics, Inc. | 1 | $56 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| CSL Behring | 1 | $40 |
| Beckman Coulter, Inc. | 1 | $26 |
| Hill-rom Company, Inc | 1 | $19 |
How this compares
$928,522 in reported general payments places this provider in the 95th percentile of 2,469 hospitalist providers in California.
Other hospitalist in Orange
- Anjani KolahiOrange$30K
- Omar DarwishOrange$22K
- Thomas KimOrange$5K
- John BeckesNational City$15.5M
- Samuel PenzinerLos Angeles$2.5M
- Michael Abdel-MalekDublin$2M
- Billy HourMission Hills$1.9M
- Jennifer SchneiderSanta Rosa$1.2M
- Soham ShahBakersfield$844K
- Deanna CheungLong Beach$732K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.